This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gottlieb, E.
Right arrow Articles by Thompson, C. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gottlieb, E.
Right arrow Articles by Thompson, C. B.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, August 2000, p. 5680-5689, Vol. 20, No. 15
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

Bcl-xL Prevents the Initial Decrease in Mitochondrial Membrane Potential and Subsequent Reactive Oxygen Species Production during Tumor Necrosis Factor Alpha-Induced Apoptosis

Eyal Gottlieb, Matthew G. Vander Heiden, and Craig B. Thompson*

Abramson Family Cancer Research Institute, University of Pennsylvania, Philadelphia, Pennsylvania 19104

Received 9 February 2000/Returned for modification 4 April 2000/Accepted 6 May 2000


    ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

The Bcl-2 family of proteins are involved in regulating the redox state of cells. However, the mode of action of Bcl-2 proteins remains unclear. This work analyzed the effects of Bcl-xL on the cellular redox state after treatment with tumor necrosis factor alpha (TNF-alpha ) or exogenous oxidants. We show that in cells that undergo TNF-alpha -induced apoptosis, TNF-alpha induces a partial decrease in mitochondrial membrane potential (Delta Psi m) followed by high levels of reactive oxygen species (ROS). ROS scavengers delay the progression of mitochondrial depolarization and apoptotic cell death. This indicates that ROS are important mediators of mitochondrial depolarization. However, ROS scavengers fail to prevent the initial TNF-alpha -induced decrease in Delta Psi m. In contrast, expression of Bcl-xL prevents both the initial decrease in Delta Psi m following TNF-alpha treatment and the subsequent induction of ROS. Bcl-xL itself does not act as a ROS scavenger. In addition, Bcl-xL does not block the initial decrease in Delta Psi m following treatment with the oxidant hydrogen peroxide. However, unlike control-transfected cells, Bcl-xL-expressing cells can recover their mitochondrial membrane potential following the initial drop in Delta Psi m induced by hydrogen peroxide. These data suggest that Bcl-xL plays a regulatory role in controlling the membrane potential of and ROS production by mitochondria rather than acting as a direct antioxidant.


    INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

The redox state of a cell is an important factor in determining its susceptibility to different apoptotic stimuli (for a recent review, see reference 18). Both reactive oxygen species (ROS), which are prooxidants, and thiol compounds, which act as antioxidants, play a critical role in regulating apoptosis following the application of apoptotic stimuli such as tumor necrosis factor alpha (TNF-alpha ) (24), Fas signaling (1), glucocorticoids (31), thiol depletion (12, 16, 22), radiation (19), chemotherapeutic agents (4), ceramide (20), and lymphocyte activation (8). However, the mechanism by which the cellular redox state is regulated during apoptosis and its role in modulating cell death remain unclear.

All aerobic cells generate ROS in the form of superoxide anions, hydrogen peroxides, organic peroxides, and hydroxyl radicals (3). Since ROS are by-products of oxidative phosphorylation, most cellular ROS are produced by mitochondria. Superoxide radicals are produced when oxygen is reduced by a single electron; this occurs mostly at the ubiquinone site of complex III of the mitochondrial electron transport chain. However, electron transfer in other cellular organelles, such as the endoplasmic reticulum and nuclear and plasma membranes, can also produce superoxides. Moreover, several biochemical reactions other than electron transport chains can produce ROS. For example, the catabolism of purine nucleotides (xanthine oxidase reaction), the metabolism of fatty acids, in particular the production of prostaglandins and leukotrienes from arachidonic acid (lipoxygenase reaction), and many biochemical reactions that take place in peroxisomes can produce ROS (3). ROS produced at sites other than mitochondria have been reported to be involved in some apoptotic systems, but it is widely accepted that mitochondria are the predominant source of ROS produced in most apoptotic systems (14, 18).

Mitochondrial homeostasis is critical in regulating apoptosis (6, 14). In particular, it has been noted that some or all of the following mitochondrial changes are associated with apoptosis: mitochondrial membrane hyperpolarization and depolarization, matrix swelling, and permeability of the outer membrane, resulting in the release of proapoptotic proteins such as cytochrome c, apoptosis-inducing factor, and potentially other proteins. In many instances, such mitochondrial events are a prerequisite for the activation of a family of aspartic acid-specific, cysteine-containing proteases (caspases) that are known to be important mediators of apoptosis (21, 25). Other mitochondrion-related cellular alterations that are important in modulating the apoptotic process can also occur. These include a decreased ATP/ADP ratio, thiol depletion, and ROS induction (6, 14).

The Bcl-2 family of proteins are ubiquitous regulators of cell death (7, 28). The mechanism of action of several members of this family appears to involve mitochondria. Bcl-2 and Bcl-xL exert at least some of their antiapoptotic effect by regulating mitochondrial homeostasis, in particular by maintaining mitochondrial-cytosolic coupling of oxidative phosphorylation (7, 28). In addition, Bcl-2 proteins can modulate the release of apoptogenic factors, such as cytochrome c and apoptosis-inducing factor, from mitochondria. There are also some indications that Bcl-2 and Bcl-xL may function as antioxidants and in this way exert anti-apoptotic activity. Bcl-2 knockout (Bcl-2-/-) mice are hypopigmented due to a defect in melanin synthesis, which itself is redox regulated (29). Moreover, enhanced oxidative stress and a higher susceptibility to prooxidants are evident in the brains of Bcl-2-/- mice compared to control mice (9). Bcl-2 protects cells from hydrogen peroxide- or thiol depletion-induced death and suppresses lipid peroxidation (10, 12, 19, 26). There are two mechanisms that can explain the antioxidant activity of Bcl-2 proteins. In the first mechanism, Bcl-2 maintains cells in a more reduced state by scavenging ROS either directly or by up-regulating other ROS scavengers such as thiol compounds. Alternatively, or in addition, Bcl-2 may function to prevent the generation of ROS during apoptosis. It remains unclear how Bcl-2-like proteins antagonize oxidation. However, since Bcl-2 was shown to protect cells from death induced by exogenous oxidant compounds such as hydrogen peroxide or lipid peroxide (10, 26), it has been considered likely that Bcl-2 proteins act downstream of ROS formation.

Here we further elucidate the role of Bcl-2 proteins in determining the redox state of cells. In response to TNF-alpha treatment, cells produced elevated levels of ROS. However, this production of ROS occurred only after TNF-alpha induced a reduction in the mitochondrial membrane potential (Delta Psi m). ROS scavengers did not interfere with the initial decrease in Delta Psi m but significantly attenuated the subsequent mitochondrial collapse of Delta Psi m and partially rescued the cells from apoptosis. These results indicate that ROS contribute to mitochondrial membrane depolarization. Expression of Bcl-xL blocked both the initial decrease in Delta Psi m and the subsequent increase in ROS levels following TNF-alpha treatment. In contrast, Bcl-xL expression did not block the initial reduction in Delta Psi m that follows hydrogen peroxide treatment. Still, Bcl-xL expression allowed cells to recover from the hydrogen peroxide-induced drop in Delta Psi m and prevented progression to complete mitochondrial membrane depolarization. In this system, Bcl-xL did not have ROS scavenger activity. These data lead to the conclusion that Bcl-xL acts to promote mitochondrial recovery from oxidant-induced damage. Bcl-xL partially inhibits the decrease in mitochondrial respiration that begins shortly after TNF-alpha treatment. This activity of Bcl-xL can explain both the maintenance of mitochondrial Delta Psi m and the prevention of ROS production in mitochondria. Therefore, it is proposed that following TNF-alpha -induced signal transduction, Bcl-xL plays a direct regulatory role in maintaining mitochondrial physiology. In addition, these data support the hypothesis that Bcl-xL is active in regulating mitochondrial physiology even in cells that ultimately succumb to TNF-alpha -induced death.


    MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Materials. S-18 anti-Bcl-x monoclonal antibody was purchased from Santa Cruz Biotechnology. Propidium iodide (PI), tetramethylrhodamine ethyl ester (TMRE), and 2'7'-dichlorodihydrofluorescein diacetate (DCFH-DA) were purchased from Molecular Probes. 1-Pyrrolidine dithiocarbamate (PDTC) was purchased from Calbiochem. N-Acetyl-L-cysteine (NAC), carbonyl cyanide p-(trifluoromethoxy)phenylhydrazone (FCCP), and cycloheximide (CHX) were purchased from Sigma. Recombinant murine TNF-alpha was purchased from Boehringer Mannheim Biochemicals, and the modified peptide benzyloxycarbonyl (z)-Val-Ala-Asp-fluoromethyl ketone (ZVAD-fmk) was purchased from Enzyme Systems Products.

Cell culture and transfections. The 2B4.11 (2B4) T-cell hybridoma line was maintained routinely at 37°C and 5% CO2 in RPMI medium supplemented with 10% bovine calf serum and 50 µM 2-mercaptoethanol. Cells were transfected by electroporation (250 V and 960 µF) with the pSFFV-neo plasmid (control cells) or with the plasmid containing an insert encoding the human Bcl-xL cDNA. Transfected cells were selected with G418 (1 mg/ml) to generate control 2B4/neo cells and several Bcl-xL-expressing clones. Clones were generated by limiting dilution. Bcl-xL protein levels in the different clones were analyzed by Western blot analysis using the S-18 monoclonal antibody.

Cell analysis. Cells were split 1:10 a day before treatment. At 2 h before treatments, the cells were counted and replated at 105 cells/ml. To induce cell death, 200 U of TNF-alpha and 5 µg of CHX per ml were added. CHX was used to inhibit antiapoptotic pathways induced by TNF-alpha . When anti-oxidants (25 µM PDTC or 50 mM NAC) were used, they were added 1 h prior to the apoptotic stimuli.

Viability was determined by PI exclusion. Cells were incubated with PI (5 µg/ml) and analyzed immediately by fluorescence-activated cell sorter (FACS) analysis. For Delta Psi m analysis, cells were incubated with 0.2 µM TMRE for 30 min at 37°C and then subjected to FACS analysis. TMRE fluorescence was detected in live cells as determined by forward-scatter and side-scatter criteria. The mitochondrial uncoupler FCCP (10 µM), added 3 h before TMRE staining, was used to depolarize mitochondria and serves as an indicator that TMRE staining is in proportion to the mitochondrial membrane potential.

ROS levels were detected by incubating the cells with 10 µM DCFH-DA for 30 min at 37°C. ROS analysis was performed together with either PI (to determine viability) or TMRE (to analyze Delta Psi m). At each time point, cells were also stained with either PI or TMRE alone, and the mean FL1 fluorescence of these cells (FL1 background) was subtracted from that of cells that were double stained with DCFH-DA and either PI or TMRE, giving a corrected mean FL1 value. Untreated cells were used as a reference for ROS levels at each time point, and the corrected mean FL1 value of the untreated cells was defined as ROS = 1.

To detect the DCFH oxidation rate following hydrogen peroxide treatment, cells were incubated with 10 µM DCFH-DA for 30 min at 37°C and analyzed by FACS analysis for DCFH oxidation for 2 min (basal levels). This was followed by addition of hydrogen peroxide (50 nmol/105 cells) and continuous reading of DCFH oxidation for 30 min more.

Oxygen consumption assay. Cells (5 × 106 in 30 ml) were either left untreated or treated with TNF-alpha as described above. At 2 h later, cells were centrifuged and resuspended in 3 ml of medium. The oxygen consumption rate was measured in a respirometer using a polarographic oxygen electrode (Cameron Instrument Co.).


    RESULTS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Bcl-xL inhibits TNF-alpha -induced apoptosis in 2B4 T cells. We examined the role that the cellular redox state plays during apoptosis, particularly the roles of ROS in initiating apoptotic events and of Bcl-xL in controlling such events. TNF-alpha increases cellular ROS levels during apoptosis (24), and lymphocytes are sensitive to ROS-mediated cell death (31). The TNF-alpha -sensitive murine T-cell hybridoma line 2B4 was used as a model to study redox state regulation during apoptosis. Several clones of 2B4 cells overexpressing Bcl-xL were established. The Bcl-xL protein levels of two representative Bcl-xL-expressing clones (2B4/XL c.5 and 2B4/XL c.10), as well as of the control cells transfected with the G418 resistance gene only (2B4/neo), are presented in Fig. 1A.


View larger version (38K):
[in this window]
[in a new window]
  		FIG. 1.   Bcl-xL can protect 2B4 cells from apoptosis induced by TNF-alpha . (A) Bcl-xL protein levels in 2B4-transfected cells were detected by Western blot analysis. The results for one control transfected clone (neo) and two Bcl-xL-transfected clones (XL c.5 and XL c.10) are presented. (B) Viability assay (PI exclusion) of the clones at 36 h following treatment. Cells were either left untreated or treated with TNF-alpha in the presence or absence of the caspase inhibitor ZVAD-fmk (200 µM). (C) Survival assay as described in panel B for cells treated with TNF-alpha in the presence of increasing concentrations of ZVAD-fmk. (D) Kinetics of cell death. Cells were treated with TNF-alpha , and viability was determined by PI exclusion at the indicated time points.

There is evidence to suggest that there are two types of response to death mediated by TNF receptor (TNFR) family members (23). Type I cells show high levels of caspase-8 activity within the "death-inducing signaling complex" (DISC) following Fas activation, and type II cells show lower levels of caspase-8 activity under the same conditions. Only type II cells are protected by the expression of Bcl-2. 2B4 cells are defined as type I, particularly since expression of Bcl-xL fails to block Fas-induced death (17). Indeed, when 2B4 cells were treated with TNF-alpha in the presence of the protein synthesis inhibitor CHX to prevent the induction of the antiapoptotic response induced by TNF-alpha -mediated NF-kappa B signaling, both control cells and Bcl-xL-overexpressing cells were killed at 36 h (Fig. 1B). This was a caspase-mediated cell death, since ZVAD-fmk, a general caspase inhibitor, was able to protect cells from death (Fig. 1B). Although Bcl-xL expression failed to prevent TNF-alpha -induced death, Bcl-xL lowered the amount of ZVAD-fmk necessary to protect the cells from death (Fig. 1C). The cooperative protection by Bcl-xL and ZVAD-fmk is related to the Bcl-xL protein levels (Fig. 1A and C). This indicates that once caspase activity is limited, Bcl-xL can play a role in protecting even type I cells from TNF-alpha -mediated death. Consistent with this conclusion, examination of earlier time points following TNF-alpha treatment shows that Bcl-xL has a major effect on the kinetics of cell death even in the absence of caspase inhibitors (Fig. 1D), although the cells were not ultimately protected from death.

An increase in cellular ROS levels is associated with TNF-alpha -mediated apoptosis and is blocked by Bcl-xL expression. We analyzed the involvement of ROS in apoptosis induced by TNF-alpha . Intracellular hydrogen peroxide levels were measured using the fluorescent probe DCFH-DA. This is a cell-permeant dye that, once inside the cells, is cleaved by endogenous esterase into its nonfluorescent form, DCFH. This form is no longer membrane permeant and is therefore trapped in the cells, where it is oxidized, mostly by hydrogen peroxide in the presence of peroxidase, into its fluorescent form, DCF. At different time points following treatment, the cells were stained with DCFH-DA for 30 min followed by PI and then subjected to FACS analysis. Only the population of living cells, as indicated by their ability to exclude PI, was analyzed, and the ratio of the mean fluorescence of TNF-alpha -treated to untreated live cells is presented (Fig. 2A).


View larger version (17K):
[in this window]
[in a new window]
  		FIG. 2.   ROS scavengers can delay apoptosis of TNF-alpha -treated cells. (A) Parental 2B4 cells were incubated with TNF-alpha for 6 h without (control) or with ROS scavengers (NAC or PDTC). Untreated cells were incubated as a reference for ROS levels. DCFH-DA was then added to the cells, and the cells were further incubated for 30 min. PI was added just prior to FACS analysis. DCFH oxidation was analyzed only in live cells (PI negative). ROS levels are defined as the ratio between the mean fluorescence of treated and untreated cells (see Materials and Methods). (B) Kinetics of cell death. Cells were treated as in panel A, and viability was measured by PI exclusion at the indicated time points.

A more than 10-fold increase in ROS levels was observed in parental 2B4 cells at 6 h following TNF-alpha treatment (Fig. 2A). Although only live cells were analyzed in this assay, it could be argued that ROS are early by-products of cell death. Therefore, to establish that ROS contribute directly to this apoptotic process, 2B4 cells were treated with TNF-alpha in the presence or absence of antioxidants. NAC and PDTC are potent ROS scavengers. These two compounds reduced the ROS levels following TNF-alpha treatment (Fig. 2A) and attenuated the death induced by TNF-alpha (Fig. 2B). PDTC was a more effective antioxidant in this system and also a better protector from apoptosis (Fig. 2). These results suggest that ROS play a role in the regulation of 2B4 cell death following TNF-alpha treatment. Like the incomplete inhibition of cell death achieved by Bcl-xL expression (Fig. 1D), PDTC treatment did not completely block apoptosis but, rather, significantly delayed the process. These observations indicate that although ROS production is important for TNF-alpha -induced apoptosis in these cells, it is not essential, most probably due to a direct apoptotic signal that is mediated by caspases activated upon recruitment to TNFR (type I cells [see above]).

To check whether the ability of Bcl-xL to partially protect 2B4 cells from TNF-alpha -mediated apoptosis is correlated with a reduction in the level of TNF-alpha -induced ROS, we analyzed the ROS levels in control and Bcl-xL-expressing cells following TNF-alpha treatment. A significant and time-dependent increase in ROS levels was observed in control 2B4/neo cells at early time points following TNF-alpha treatment. This increase was completely blocked when Bcl-xL protein was expressed in these cells (Fig. 3A). These observations suggest that the partial protective effect of Bcl-xL may be due to its regulation of the cellular redox state.



View larger version (48K):
[in this window]
[in a new window]
  		FIG. 3.   Bcl-xL blocks ROS induction in TNF-alpha -treated cells but has no ROS scavenging activity. (A) Control cells (2B4/neo) and Bcl-xL-expressing cells (2B4/XL c.5 and 2B4/XL c.10) were either left untreated or treated with TNF-alpha . At the indicated time points, the cells were stained with DCFH-DA and PI, and ROS levels were analyzed as in the experiment in Fig. 2A. (B) DCFH oxidation. Untreated cells were incubated in the presence of DCFH-DA (added at time zero), and DCFH oxidation was analyzed by FACS analysis at the indicated time points. Mean fluorescence units (F.U.) represent the level of DCFH oxidation at each time point. (C) Cells were incubated with DCFH-DA for 30 min, and DCFH oxidation was measured by FACS analysis in a continuous assay. After 2 min, H2O2 (50 nmol/105 cells) was added (arrow), and DCFH oxidation was measured for a further 30 min.

Bcl-xL is not a direct antioxidant but plays a regulatory role in preventing ROS production. Two ways to explain the block of ROS induction by Bcl-xL are available. Bcl-xL can work downstream of the point of ROS production by promoting ROS scavenger activity either directly or by up-regulating other ROS scavengers. Alternatively, Bcl-xL can block the increase in ROS levels by altering upstream events that lead to ROS production. To determine whether Bcl-xL can interfere with the oxidation rate of DCFH simply by acting as a ROS scavenger, untreated 2B4/neo and Bcl-xL-overexpressing cells (2B4/XL c.10) were incubated in the presence of DCFH-DA and the fluorescence level was analyzed over time (Fig. 3B). It is notable that Bcl-xL does not act as a direct inhibitor of DCFH oxidation since the rate of DCFH oxidation during the incubation of untreated cells was indistinguishable between 2B4/neo and 2B4/XL c.10 cells. Moreover, these results also indicate that the basal redox state (DCFH fluorescence) of these cells is comparable and unaffected by the expressed Bcl-xL protein. To rule out the possibility that Bcl-xL may adapt an antioxidant activity following the generation of ROS, the response of 2B4/neo and 2B4/XL c.10 cells to oxidative stress was analyzed. The kinetics of DCFH oxidation immediately after the addition of exogenous hydrogen peroxide (50 nmol/105 cells) was detected by FACS analysis over time. Both cell lines oxidized DCFH at the same rate over the first 30 min following the addition of hydrogen peroxide (Fig. 3C). These observations support the idea that Bcl-xL works upstream of the point of ROS production during apoptosis and are inconsistent with the hypothesis that Bcl-xL itself acts as a ROS scavenger or induces ROS scavenging activity.

An increase in ROS precedes mitochondrial depolarization during apoptosis. Bcl-2 and Bcl-xL block mitochondrial depolarization in many apoptotic systems. We sought to determine the relationship between Bcl-xL, mitochondrial depolarization and ROS levels. To quantify Delta Psi m, TMRE, a potentiometric fluorescent dye that incorporates into mitochondria in a Delta Psi m-dependent manner, was used. Cells were either left untreated or treated with TNF-alpha for 3 h in the presence or absence of the ROS scavenger PDTC. The cells were then stained with TMRE for 30 min and analyzed by FACS analysis. As can be seen in Fig. 4A, a decrease in Delta Psi m was observed in 2B4/neo cells following TNF-alpha treatment. FCCP, a protonophore that induces a collapse of Delta Psi m, was used as a control for TMRE staining (Fig. 4A and B). The decrease in Delta Psi m observed 3 h after TNF-alpha treatment was only a partial mitochondrial depolarization compared to the complete mitochondrial depolarization observed in FCCP-treated cells. The expression of Bcl-xL completely blocked this decrease in Delta Psi m at this time point (Fig. 4B). In contrast, the ROS scavenger, PDTC, which strongly protects these cells from apoptosis induced by TNF-alpha (Fig. 2B), could not protect them from the initial decrease in Delta Psi m following the same treatment (Fig. 4C).


View larger version (21K):
[in this window]
[in a new window]
  		FIG. 4.   Unlike Bcl-xL, ROS scavengers cannot protect cells from the initial decrease in Delta Psi m following TNF-alpha treatment. TMRE staining followed by FACS analysis was used to monitor the Delta Psi m in untreated cells (shaded area), in cells treated with TNF-alpha for 3 h (thick line) or in cells treated with FCCP for 3 h (dashed line). Only live cells (as judged by forward-scatter and side-scatter criteria) were analyzed. (A) Control cells (2B4/neo). (B) Bcl-xL-expressing cells (2B4/XL c.10). (C) 2B4/neo cells treated as above in the presence of the ROS scavenger PDTC.

Since Bcl-xL can block both the decrease of Delta Psi m (Fig. 4B) and the increase in ROS levels following TNF-alpha treatment (Fig. 3A), it is possible that these two events are related. To address this issue, cells were assayed simultaneously for both ROS levels and Delta Psi m. When cells were doubly labeled with TMRE and DCFH-DA, the ROS levels in cells before and during mitochondrial depolarization could be differentiated and measured. The processes of mitochondrial depolarization and ROS induction following TNF-alpha treatment appeared to occur in several stages (Fig. 5). First, cells were shifted from a high-Delta Psi m state (TH) into a decreased-Delta Psi m state (TM). At this point, an increase in ROS production was observed (Fig. 5B). This state (TM) was followed by a further depolarization of the mitochondria into a low-Delta Psi m state (TL). Then the cells lost viability as judged by size (forward-scatter) and granularity (side-scatter) criteria (green cells). It is noteworthy that in these cells, the extent of death measured by forward-scatter and side-scatter criteria was comparable to that assayed by PI exclusion (data not shown). This course of events in 2B4 cells suggested that ROS may play a role in the second depolarization (from TM to TL) during the apoptotic cascade following TNF-alpha treatment. This hypothesis is supported by the observation that the ROS scavenger PDTC significantly attenuated the escalation in mitochondrial depolarization but could not prevent the first stage of decrease in Delta Psi m (Fig. 5A to E). Based on these results, it seems that ROS are not absolutely required for a complete mitochondrial depolarization but, rather, significantly accelerate this process. As early as 6 h after TNF-alpha treatment, only 8.5% of the control cells still maintained some Delta Psi m (Fig. 5C), while on addition of PDTC, 32.7% of the cells still maintained a Delta Psi m (Fig. 5E). However, a substantial number of cells were completely depolarized at this time point even in the presence of PDTC, and all the cells eventually died despite the ability of PDTC to keep ROS levels low (Fig. 2). On the other hand, unlike the results with PDTC, Bcl-xL inhibited the initial decrease in Delta Psi m that preceded ROS induction and it completely blocked the increase in ROS levels (Fig. 5G and H). Therefore, it is likely that Bcl-xL modulates ROS production during TNF-alpha -induced apoptosis by regulating the initial drop in Delta Psi m. Based on these results, it appears that ROS production increases coincidently with the initial drop in Delta Psi m. Increased ROS levels appear to further facilitate the progression of mitochondrial depolarization of apoptotic cells.


View larger version (41K):
[in this window]
[in a new window]
  		FIG. 5.   Following TNF-alpha treatment, ROS are induced after a partial decrease in Delta Psi m and are important mediators of mitochondrial membrane depolarization. Control cells (2B4/neo) and Bcl-xL-expressing cells (2B4/XL c.10) were either left untreated (A and F) or treated with TNF-alpha (B to E, G, and H). PDTC, a ROS scavenger, was added to 2B4/neo cells (D and E). At the indicated time points, cells were doubly stained with TMRE and DCFH-DA to analyze the increase in ROS levels in parallel with loss of Delta Psi m. Cells were divided by forward-scatter and side-scatter criteria into live cells (blue) and dead cells (green). Other subgroups were defined by Delta Psi m levels: TH, TMRE high; TM, TMRE medium; TL, TMRE low. Viability (V) was defined in this assay as the percentage of cells in the TH + TM subgroups. ROS levels (fold above untreated cells [see Materials and Methods]) were analyzed for viable cells only [ROS (V)].

Bcl-xL partially relieves cells from a TNF-alpha -induced decrease in respiration. One way to produce high levels of ROS from mitochondria is to use electron transport inhibitors that block respiration downstream of complex III, leaving complex III in its reduced state. Under these conditions, the rate of electron transfer from the ubiquinone site of complex III directly to oxygen molecules will increase, resulting in high levels of partially reduced oxygen in the form of superoxide radicals. Furthermore, a blockage of respiration could explain the early reduction in Delta Psi m following TNF-alpha treatment. To test whether treatment with TNF-alpha leads to a decrease in electron transport, we analyzed the respiration rates of TNF-alpha -treated cells compared to untreated cells. A significant decrease in oxygen consumption was observed in 2B4/neo cells as early as 2 h after TNF-alpha treatment (59% ± 12.5% of that in untreated cells) (Fig. 6). This observation supports the hypothesis that a respiration block develops following TNF-alpha treatment. This block was significantly alleviated by the expression of Bcl-xL (Fig. 6). The ability of Bcl-xL to maintain a higher rate of cellular respiration following TNF-alpha treatment suggests that by promoting coupled oxidative phosphorylation, Bcl-xL functions to sustain Delta Psi m and to prevent ROS production.


View larger version (26K):
[in this window]
[in a new window]
  		FIG. 6.   Inhibition of respiration induced by TNF-alpha is reversed by Bcl-xL expression. (A) Control cells (2B4/neo) and Bcl-xL-expressing cells (2B4/XL c.10) were either left untreated or treated with TNF-alpha for 2 h. Oxygen consumption was analyzed using an oxymeter (see Materials and Methods), and the decrease in oxygen pressure in the chamber over time is presented for each sample. (B) For each treatment, the average slopes of the graphs obtained in panel A, calculated from three independent experiments, are presented. This value describes the average rate of oxygen consumption by the cells (presented as the decrease in oxygen pressure per second per 106 cells).

Bcl-xL protects cells from exogenous oxidant-induced apoptosis by blocking the escalation in the mitochondrial depolarization process. The above results indicate that Bcl-xL works upstream of ROS production and cannot reduce oxidation stress once ROS are produced or introduced into the cells. It is challenging to reconcile these observations with reports that Bcl-xL protects cells from death induced by exogenous hydrogen peroxide (10). In 2B4 cells, Bcl-xL protected cells from death induced by 50 nmol of exogenously added hydrogen peroxide per 105 cells (Fig. 7A) but provided no protection if twice the amount of hydrogen peroxide was used. The same restriction in the ability to protect cells from hydrogen peroxide-induced death was previously described for Bcl-2 and was attributed to its limited ROS scavenger capacity (10). However, at 50 nmol/105 cells, hydrogen peroxide induced an initial mitochondrial depolarization 3 h after treatment that was comparable in control transfected cells and Bcl-xL-expressing cells (Fig. 7B; green histograms), yet Bcl-xL expression prevented further depolarization in the subsequent 3 h whereas control cells continued to decrease their TMRE uptake. At 12 h posttreatment, Delta Psi m began to recover in the Bcl-xL-expressing cells (Fig. 7B). When 100 nmol of hydrogen peroxide per 105 cells was used, Bcl-xL did not protect cells from further depolarization (data not shown), and rapid cell death occurred (Fig. 7A).


View larger version (27K):
[in this window]
[in a new window]
  		FIG. 7.   Bcl-xL protects 2B4 cells from hydrogen peroxide by preventing a complete drop in Delta Psi m and allowing its recovery. (A) Control cells (2B4/neo) and Bcl-xL-overexpressing cells (2B4/XL c.10) were treated with the indicated amounts of hydrogen peroxides, and viability was determined by PI exclusion 12 h later. (B) Cells were treated with hydrogen peroxide (50 nmol/105 cells) and at the indicated time points, stained with TMRE, and subjected to FACS analysis to determine their Delta Psi m. Only live cells (as judged by forward-scatter and side-scatter criteria) were analyzed.


    DISCUSSION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

TNF-alpha alters ROS levels in many cellular systems (24, 30). ROS are important mediators of cell death in lymphocytes following different apoptotic stimuli, such as Fas signaling (1), glucocorticoid treatment (10, 31), and activation-induced cell death (8). We used the TNF-alpha -treated mouse T-cell hybridoma cell line 2B4 as a cellular model to study the role of Bcl-xL in regulating the redox state of cells in response to an apoptotic signal.

Bcl-xL-regulated pathways can contribute to the death induced by TNF-alpha in type I cells. Both Bcl-2 and antioxidants protect some cell types from apoptosis initiated through death receptor signal transduction. Here we show that Bcl-xL protects even type I cells from mitochondrial changes and death induced by TNFR signaling. 2B4 cells are type I cells in their response to Fas signaling (17). This definition implies that the mitochondrial proapoptotic pathway is dispensable in these cells and that Bcl-xL does not protect them from Fas-induced apoptosis (23). Here we report that although Bcl-xL could not rescue 2B4 cells from apoptosis induced by TNF-alpha , both Bcl-xL-dependent and Bcl-xL-independent mechanisms are required for efficient induction of cell death. We demonstrate that Bcl-xL blocks TNF-alpha -induced mitochondrial changes (Fig. 4 and 5) and significantly attenuates the rate of death (Fig. 1D). Moreover, a potent ability of Bcl-xL to protect from TNF-alpha -induced apoptosis is revealed once caspase activity is restricted (Fig. 1C). This is in line with other results obtained with another lymphoid cell line, the pro-B cells FL5.12 (11). It therefore seems that the antiapoptotic Bcl-2-like proteins may function to protect mitochondria even in type I cells following TNF-alpha treatment. This raises the question whether, under physiological conditions, where death-inducing ligands are limiting, synergism between mitochondrion-dependent and mitochondrion-independent apoptotic machineries is critical to determine whether a cell will live or die. In such a scenario, Bcl-2 or Bcl-xL expression would confer a survival advantage in response to limited TNFR signal transduction.

Bcl-xL reduces ROS levels during apoptosis by blocking ROS production. In TNF-alpha -treated cells, ROS are produced after a partial drop in Delta Psi m and are important mediators of the complete mitochondrial depolarization (Fig. 5). Bcl-xL was shown in our system to prevent the induction of ROS levels following TNF-alpha treatment (Fig. 3A). When the basal levels of ROS in untreated cells were analyzed by DCFH oxidation, there was no detectable difference between the levels in control cells and in Bcl-xL-expressing cells (Fig. 3B). These results support the idea that Bcl-xL expression does not maintain more reduced conditions in these cells during normal proliferation. In addition, the observation that the expression of Bcl-xL did not reduce the initial rate of DCFH oxidation in hydrogen peroxide-treated cells (Fig. 3C) further supports the hypothesis that Bcl-xL regulates ROS levels at or upstream of the point of ROS production.

Since ROS were induced after the first decrease in Delta Psi m (Fig. 5) and Bcl-xL blocked that decrease, it is possible that the decrease in Delta Psi m is the cause of ROS production. A decrease in Delta Psi m can occur by one of two mechanisms. In the first, making the mitochondrial inner membrane more permeable to protons will dissipate the proton gradient across this membrane. Alternatively, a decrease in electron transport will result in fewer protons being pumped from the matrix to the intermembrane space and will eventually lead to decreased Delta Psi m. The first mechanism is more likely to lead to a complete collapse of Delta Psi m and is probably important for the final mitochondrial depolarization, while the second mechanism could explain the initial partial reduction of Delta Psi m. Theoretically, both mechanisms would lead to a drop of Delta Psi m and could result in increased formation of ROS. For example, increased inner mitochondrial membrane permeability to protons would increase the rate of electron transport in this membrane, and thus the rate of partially reduced oxygen molecules (ROS production) would increase proportionately. However, since FCCP, a protonophore that induces a collapse of Delta Psi m, does not significantly increase ROS levels in these cells (data not shown), it appears unlikely that this is the mechanism by which ROS is induced during apoptosis. Moreover, a decrease in respiration rate was observed early after TNF-alpha treatment (Fig. 6). Therefore, ROS production is probably due to the partial reduction of Delta Psi m that occurs when the respiration rate decreases. A block in respiration downstream of complex III would result in a constitutively reduced complex III that would supply continuous single-electron transport directly to oxygen and so would induce high levels of superoxide radicals. Therefore, the ability of Bcl-xL to maintain respiration following TNF-alpha treatment could explain both the prevention of the initial decrease in Delta Psi m and the prevention of ROS production.

Although the ability of TNF-alpha treatment to inhibit respiration has been reported (13, 15), the reason for the TNF-alpha -induced decrease in respiration is unclear. Fas signaling has been suggested to block respiration by inactivating or releasing cytochrome c (13). TNF-alpha signal transduction also induces ceramide production, and ceramide has been reported to inhibit complex III of the respiratory chain (5). More detailed bioenergetic studies are needed to determine the mechanism by which TNF-alpha signal transduction decreases respiration. However, the ability of Bcl-xL to at least partially inhibit TNF-alpha -induced changes in respiration suggest that Bcl-xL functions to maintain mitochondrial physiology following TNF-alpha treatment. This is consistent with the recent report that Bcl-xL functions to maintain mitochondrial metabolite exchange following growth factor withdrawal, thus maintaining efficient coupling of oxidative phosphorylation in response to changes in cellular bioenergetics (27). The more efficiently coupled these processes are, the less likely the rate of respiratory ROS production is to change.

How does Bcl-xL protect from death due to treatment with exogenous ROS? Once ROS levels are induced, they appear to accelerate mitochondrial depolarization (Fig. 5 and 7B). The role of ROS in subsequent apoptotic steps is not clear. ROS may induce membrane peroxidation, leading to destabilization of the mitochondrial and/or other cellular membranes. ROS may be required to create a redox environment that facilitates the function of other proapoptotic proteins.

Adding exogenous ROS to 2B4 cells results in partial membrane depolarization regardless of Bcl-xL expression. This observation, along with the one that Bcl-xL does not induce ROS scavenging (Fig. 3), supports the hypothesis that in TNF-alpha -treated cells Bcl-xL regulates the membrane potential upstream of ROS production and that exogenous ROS therefore bypass the Bcl-xL effect. However, Bcl-xL protected cells from hydrogen peroxide-induced death (Fig. 7A), suggesting that Bcl-xL must somehow limit ROS toxicity even when ROS generation is beyond its control. Interestingly, it was recently reported that cells treated with hydrogen peroxide required further mitochondrial changes as a secondary death mediator in order to achieve full toxicity of the treatment (2). This observation supports our conclusion that Bcl-xL protects cells from certain levels of hydrogen peroxide by regulating mitochondrial functions and not by scavenging the exogenous ROS. Indeed, treatment with TNF-alpha , as well as with hydrogen peroxide, resulted in further mitochondrial depolarization before cell death was observed. The steps in mitochondrial depolarization could be part of an amplification loop that involves initial depolarization and ROS production that in turn leads to further mitochondrial dysfunction and depolarization. We have shown that Bcl-xL expression cannot reduce ROS levels in cells treated with exogenous hydrogen peroxides for the first 30 min after treatment (Fig. 3C). However, Bcl-xL may inhibit the amplification loop in hydrogen peroxide-treated cells, thus restricting depolarization of the mitochondria and allowing cells to eventually recover (Fig. 7B). Nevertheless, there is a point when the amount of exogenously supplied hydrogen peroxide is sufficient to cause complete depolarization, so that amplification is not required and Bcl-xL will fail to protect cells from death.


    ACKNOWLEDGMENTS

Parental 2B4.11 cells were a gift from J. Ashwell. We thank Tanya Gottlieb and Ayala King for helpful discussions and expert editorial advice.

Eyal Gottlieb was supported by a fellowship from the European Molecular Biology Organization (EMBO).


    FOOTNOTES

* Corresponding author. Mailing address: Abramson Family Cancer Research Institute, University of Pennsylvania, 421 Curie Blvd. BRB II/III Rm. 450, Philadelphia, PA 19104-6160. Phone: (215) 746-5515. Fax: (215) 746-5511. E-mail: craig{at}mail.med.upenn.edu.


    REFERENCES
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

1. Banki, K., E. Hutter, N. J. Gonchoroff, and A. Perl. 1999. Elevation of mitochondrial transmembrane potential and reactive oxygen intermediate levels are early events and occur independently from activation of caspases in Fas signaling. J. Immunol. 162:1466-1479[Abstract/Free Full Text].
2. Dumont, A., S. P. Hehner, T. G. Hofmann, M. Ueffing, W. Droge, and M. L. Schmitz. 1999. Hydrogen peroxide-induced apoptosis is CD95-independent, requires the release of mitochondria-derived reactive oxygen species and the activation of NF-kappaB. Oncogene 18:747-757[CrossRef][Medline].
3. Freeman, B. A., and J. D. Crapo. 1982. Biology of disease: free radicals and tissue injury. Lab. Investig. 47:412-426[Medline].
4. Friesen, C., S. Fulda, and K. M. Debatin. 1999. Induction of CD95 ligand and apoptosis by doxorubicin is modulated by the redox state in chemosensitive- and drug-resistant tumor cells. Cell Death Differ. 6:471-480[CrossRef][Medline].
5. Garcia-Ruiz, C., A. Colell, M. Mari, A. Morales, and J. C. Fernandez-Checa. 1997. Direct effect of ceramide on the mitochondrial electron transport chain leads to generation of reactive oxygen species. Role of mitochondrial glutathione. J. Biol. Chem. 272:11369-11377[Abstract/Free Full Text].
6. Green, D. R., and J. C. Reed. 1998. Mitochondria and apoptosis. Science 281:1309-1312[Abstract/Free Full Text].
7. Gross, A., J. M. McDonnell, and S. J. Korsmeyer. 1999. BCL-2 family members and the mitochondria in apoptosis. Genes Dev. 13:1899-1911[Free Full Text].
8. Hildeman, D. A., T. Mitchell, T. K. Teague, P. Henson, B. J. Day, J. Kappler, and P. C. Marrack. 1999. Reactive oxygen species regulate activation-induced T cell apoptosis. Immunity 10:735-744[CrossRef][Medline].
9. Hochman, A., H. Sternin, S. Gorodin, S. Korsmeyer, I. Ziv, E. Melamed, and D. Offen. 1998. Enhanced oxidative stress and altered antioxidants in brains of Bcl-2-deficient mice. J. Neurochem. 71:741-748[Medline].
10. Hockenbery, D. M., Z. N. Oltvai, X. M. Yin, C. L. Milliman, and S. J. Korsmeyer. 1993. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75:241-251[CrossRef][Medline].
11. Johnson, B. W., and L. H. Boise. 1999. Bcl-2 and caspase inhibition cooperate to inhibit tumor necrosis factor-alpha-induced cell death in a Bcl-2 cleavage-independent fashion. J. Biol. Chem. 274:18552-18558[Abstract/Free Full Text].
12. Kane, D. J., T. A. Sarafian, R. Anton, H. Hahn, E. B. Gralla, J. S. Valentine, T. Ord, and D. E. Bredesen. 1993. Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species. Science 262:1274-1277[Abstract/Free Full Text].
13. Krippner, A., A. Matsuno-Yagi, R. A. Gottlieb, and B. M. Babior. 1996. Loss of function of cytochrome c in Jurkat cells undergoing fas-mediated apoptosis. J. Biol. Chem. 271:21629-21636[Abstract/Free Full Text].
14. Kroemer, G., B. Dallaporta, and M. Resche-Rigon. 1998. The mitochondrial death/life regulator in apoptosis and necrosis. Annu. Rev. Physiol. 60:619-642[CrossRef][Medline].
15. Lancaster, J. R., Jr., S. M. Laster, and L. R. Gooding. 1989. Inhibition of target cell mitochondrial electron transfer by tumor necrosis factor. FEBS Lett. 248:169-174[CrossRef][Medline].
16. Marchetti, P., D. Decaudin, A. Macho, N. Zamzami, T. Hirsch, S. A. Susin, and G. Kroemer. 1997. Redox regulation of apoptosis: impact of thiol oxidation status on mitochondrial function. Eur. J. Immunol. 27:289-296[Medline].
17. Memon, S. A., M. B. Moreno, D. Petrak, and C. M. Zacharchuk. 1995. Bcl-2 blocks glucocorticoid- but not Fas- or activation-induced apoptosis in a T cell hybridoma. J. Immunol. 155:4644-4652[Abstract].
18. Mignotte, B., and J. L. Vayssiere. 1998. Mitochondria and apoptosis. Eur. J. Biochem. 252:1-15[Medline].
19. Mirkovic, N., D. W. Voehringer, M. D. Story, D. J. McConkey, T. J. McDonnell, and R. E. Meyn. 1997. Resistance to radiation-induced apoptosis in Bcl-2-expressing cells is reversed by depleting cellular thiols. Oncogene 15:1461-1470[CrossRef][Medline].
20. Quillet-Mary, A., J. P. Jaffrezou, V. Mansat, C. Bordier, J. Naval, and G. Laurent. 1997. Implication of mitochondrial hydrogen peroxide generation in ceramide-induced apoptosis. J. Biol. Chem. 272:21388-21395[Abstract/Free Full Text].
21. Rathmell, J. C., and C. B. Thompson. 1999. The central effectors of cell death in the immune system. Annu. Rev. Immunol. 17:781-828[CrossRef][Medline].
22. Sato, N., S. Iwata, K. Nakamura, T. Hori, K. Mori, and J. Yodoi. 1995. Thiol-mediated redox regulation of apoptosis. Possible roles of cellular thiols other than glutathione in T cell apoptosis. J. Immunol. 154:3194-3203[Abstract].
23. Scaffidi, C., S. Fulda, A. Srinivasan, C. Friesen, F. Li, K. J. Tomaselli, K. M. Debatin, P. H. Krammer, and M. E. Peter. 1998. Two CD95 (APO-1/Fas) signaling pathways. EMBO J. 17:1675-1687[CrossRef][Medline].
24. Schulze-Osthoff, K., R. Beyaert, V. Vandevoorde, G. Haegeman, and W. Fiers. 1993. Depletion of the mitochondrial electron transport abrogates the cytotoxic and gene-inductive effects of TNF. EMBO J. 12:3095-3104[Medline].
25. Thornberry, N. A., and Y. Lazebnik. 1998. Caspases: enemies within. Science 281:1312-1316[Abstract/Free Full Text].
26. Tyurina, Y. Y., V. A. Tyurin, G. Carta, P. J. Quinn, N. F. Schor, and V. E. Kagan. 1997. Direct evidence for antioxidant effect of Bcl-2 in PC12 rat pheochromocytoma cells. Arch. Biochem. Biophys. 344:413-423[CrossRef][Medline].
27. Vander Heiden, M. G., N. S. Chandel, X. X. Li, P. T. Schumacker, M. Colombini, and C. B. Thompson. 2000. Outer mitochondrial membrane permeability can regulate coupled respiration and cell survival. Proc. Natl. Acad. Sci. USA 97:4666-4671[Abstract/Free Full Text].
28. Vander Heiden, M. G., and C. B. Thompson. 1999. Bcl-2 proteins: regulators of apoptosis or of mitochondrial homeostasis? Nat. Cell Biol. 1:E209-E216[CrossRef][Medline].
29. Veis, D. J., C. M. Sorenson, J. R. Shutter, and S. J. Korsmeyer. 1993. Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell 75:229-240[CrossRef][Medline].
30. Wong, G. H., and D. V. Goeddel. 1988. Induction of manganous superoxide dismutase by tumor necrosis factor: possible protective mechanism. Science 242:941-944[Abstract/Free Full Text].
31. Zamzami, N., P. Marchetti, M. Castedo, D. Decaudin, A. Macho, T. Hirsch, S. A. Susin, P. X. Petit, B. Mignotte, and G. Kroemer. 1995. Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. J. Exp. Med. 182:367-377[Abstract/Free Full Text].

Molecular and Cellular Biology, August 2000, p. 5680-5689, Vol. 20, No. 15
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Sun, L., Chen, T., Wang, X., Chen, Y., Wei, X. (2009). Bufalin Induces Reactive Oxygen Species Dependent Bax Translocation and Apoptosis in ASTC-a-1 Cells. Evid Based Complement Alternat Med 0: nep082v1-nep082 [Abstract] [Full Text]  
  • Luciani, D. S., Gwiazda, K. S., Yang, T.-L. B., Kalynyak, T. B., Bychkivska, Y., Frey, M. H.Z., Jeffrey, K. D., Sampaio, A. V., Underhill, T. M., Johnson, J. D. (2009). Roles of IP3R and RyR Ca2+ Channels in Endoplasmic Reticulum Stress and {beta}-Cell Death. Diabetes 58: 422-432 [Abstract] [Full Text]  
  • Xiao, D., Powolny, A. A., Singh, S. V. (2008). Benzyl Isothiocyanate Targets Mitochondrial Respiratory Chain to Trigger Reactive Oxygen Species-dependent Apoptosis in Human Breast Cancer Cells. J. Biol. Chem. 283: 30151-30163 [Abstract] [Full Text]  
  • Schulz, E., Dopheide, J., Schuhmacher, S., Thomas, S. R., Chen, K., Daiber, A., Wenzel, P., Munzel, T., Keaney, J. F. Jr (2008). Suppression of the JNK Pathway by Induction of a Metabolic Stress Response Prevents Vascular Injury and Dysfunction. Circulation 118: 1347-1357 [Abstract] [Full Text]  
  • Ge, Y., Byun, J. S., De Luca, P., Gueron, G., Yabe, I. M., Sadiq-Ali, S. G., Figg, W. D., Quintero, J., Haggerty, C. M., Li, Q. Q., De Siervi, A., Gardner, K. (2008). Combinatorial Antileukemic Disruption of Oxidative Homeostasis and Mitochondrial Stability by the Redox Reactive Thalidomide 2-(2,4-Difluoro-phenyl)-4,5,6,7-tetrafluoro-1H-isoindole-1,3(2H)-dione (CPS49) and Flavopiridol. Mol. Pharmacol. 74: 872-883 [Abstract] [Full Text]  
  • Zhang, N., Peairs, J. J., Yang, P., Tyrrell, J., Roberts, J., Kole, R., Jaffe, G. J. (2007). The Importance of Bcl-xL in the Survival of Human RPE Cells. IOVS 48: 3846-3853 [Abstract] [Full Text]  
  • Han, Y. H., Kim, S. Z., Kim, S. H., Park, W. H. (2007). Arsenic trioxide inhibits growth of As4.1 juxtaglomerular cells via cell cycle arrest and caspase-independent apoptosis. Am. J. Physiol. Renal Physiol. 293: F511-F520 [Abstract] [Full Text]  
  • Yang, C., Jo, S.-H., Csernus, B., Hyjek, E., Liu, Y., Chadburn, A., Wang, Y. L. (2007). Activation of Peroxisome Proliferator-Activated Receptor {gamma} Contributes to the Survival of T Lymphoma Cells by Affecting Cellular Metabolism. Am. J. Pathol. 170: 722-732 [Abstract] [Full Text]  
  • Chen, X., Ding, W.-X., Ni, H.-M., Gao, W., Shi, Y.-H., Gambotto, A. A., Fan, J., Beg, A. A., Yin, X.-M. (2007). Bid-Independent Mitochondrial Activation in Tumor Necrosis Factor Alpha-Induced Apoptosis and Liver Injury. Mol. Cell. Biol. 27: 541-553 [Abstract] [Full Text]  
  • Jo, S.-H., Yang, C., Miao, Q., Marzec, M., Wasik, M. A., Lu, P., Wang, Y. L. (2006). Peroxisome Proliferator-Activated Receptor {gamma} Promotes Lymphocyte Survival through Its Actions on Cellular Metabolic Activities. J. Immunol. 177: 3737-3745 [Abstract] [Full Text]  
  • Mur, L. A. J., Carver, T. L. W., Prats, E. (2006). NO way to live; the various roles of nitric oxide in plant-pathogen interactions. J Exp Bot 57: 489-505 [Abstract] [Full Text]  
  • Ilan, E., Tirosh, O., Madar, Z. (2005). Triacylglycerol-Mediated Oxidative Stress Inhibits Nitric Oxide Production in Rat Isolated Hepatocytes. J. Nutr. 135: 2090-2095 [Abstract] [Full Text]  
  • Singh, S. V., Srivastava, S. K., Choi, S., Lew, K. L., Antosiewicz, J., Xiao, D., Zeng, Y., Watkins, S. C., Johnson, C. S., Trump, D. L., Lee, Y. J., Xiao, H., Herman-Antosiewicz, A. (2005). Sulforaphane-induced Cell Death in Human Prostate Cancer Cells Is Initiated by Reactive Oxygen Species. J. Biol. Chem. 280: 19911-19924 [Abstract] [Full Text]  
  • Pozniakovsky, A. I., Knorre, D. A., Markova, O. V., Hyman, A. A., Skulachev, V. P., Severin, F. F. (2005). Role of mitochondria in the pheromone- and amiodarone-induced programmed death of yeast. JCB 168: 257-269 [Abstract] [Full Text]  
  • Kang, Y.-H., Yi, M.-J., Kim, M.-J., Park, M.-T., Bae, S., Kang, C.-M., Cho, C.-K., Park, I.-C., Park, M.-J., Rhee, C. H., Hong, S.-I., Chung, H. Y., Lee, Y.-S., Lee, S.-J. (2004). Caspase-Independent Cell Death by Arsenic Trioxide in Human Cervical Cancer Cells: Reactive Oxygen Species-Mediated Poly(ADP-ribose) Polymerase-1 Activation Signals Apoptosis-Inducing Factor Release from Mitochondria. Cancer Res. 64: 8960-8967 [Abstract] [Full Text]  
  • Fribley, A., Zeng, Q., Wang, C.-Y. (2004). Proteasome Inhibitor PS-341 Induces Apoptosis through Induction of Endoplasmic Reticulum Stress-Reactive Oxygen Species in Head and Neck Squamous Cell Carcinoma Cells. Mol. Cell. Biol. 24: 9695-9704 [Abstract] [Full Text]  
  • Chang, T.-S., Cho, C.-S., Park, S., Yu, S., Kang, S. W., Rhee, S. G. (2004). Peroxiredoxin III, a Mitochondrion-specific Peroxidase, Regulates Apoptotic Signaling by Mitochondria. J. Biol. Chem. 279: 41975-41984 [Abstract] [Full Text]  
  • Nagy, G., Barcza, M., Gonchoroff, N., Phillips, P. E., Perl, A. (2004). Nitric Oxide-Dependent Mitochondrial Biogenesis Generates Ca2+ Signaling Profile of Lupus T Cells. J. Immunol. 173: 3676-3683 [Abstract] [Full Text]  
  • Krakstad, C., Christensen, A. E., Doskeland, S. O. (2004). cAMP protects neutrophils against TNF-{alpha}-induced apoptosis by activation of cAMP-dependent protein kinase, independently of exchange protein directly activated by cAMP (Epac). J. Leukoc. Biol. 76: 641-647 [Abstract] [Full Text]  
  • Edelberg, J. M., Wong, A., Holm, J. M., Xaymardan, M., Duignan, I., Chin, A., Kizer, J. R., Cai, D. (2004). Phage display identification of age-associated TNF{alpha}-mediated cardiac oxidative induction. Physiol. Genomics 18: 255-260 [Abstract] [Full Text]  
  • Buccellato, L. J., Tso, M., Akinci, O. I., Chandel, N. S., Budinger, G. R. S. (2004). Reactive Oxygen Species Are Required for Hyperoxia-induced Bax Activation and Cell Death in Alveolar Epithelial Cells. J. Biol. Chem. 279: 6753-6760 [Abstract] [Full Text]  
  • Wu, S., Zhu, H., Gu, J., Zhang, L., Teraishi, F., Davis, J. J., Jacob, D. A., Fang, B. (2004). Induction of Apoptosis and Down-Regulation of Bcl-XL in Cancer Cells by a Novel Small Molecule, 2[ [3-(2,3-Dichlorophenoxy)propyl]amino]ethanol. Cancer Res. 64: 1110-1113 [Abstract] [Full Text]  
  • Sade, H., Krishna, S., Sarin, A. (2004). The Anti-apoptotic Effect of Notch-1 Requires p56lck-dependent, Akt/PKB-mediated Signaling in T Cells. J. Biol. Chem. 279: 2937-2944 [Abstract] [Full Text]  
  • Kim, J.-Y., Ahn, H.-J., Ryu, J.-H., Suk, K., Park, J.-H. (2004). BH3-only Protein Noxa Is a Mediator of Hypoxic Cell Death Induced by Hypoxia-inducible Factor 1{alpha}. JEM 199: 113-124 [Abstract] [Full Text]  
  • Lebedeva, I. V., Su, Z.-Z., Sarkar, D., Kitada, S., Dent, P., Waxman, S., Reed, J. C., Fisher, P. B. (2003). Melanoma Differentiation Associated Gene-7, mda-7/Interleukin-24, Induces Apoptosis in Prostate Cancer Cells by Promoting Mitochondrial Dysfunction and Inducing Reactive Oxygen Species. Cancer Res. 63: 8138-8144 [Abstract] [Full Text]  
  • Nagy, G., Koncz, A., Perl, A. (2003). T Cell Activation-Induced Mitochondrial Hyperpolarization Is Mediated by Ca2+- and Redox-Dependent Production of Nitric Oxide. J. Immunol. 171: 5188-5197 [Abstract] [Full Text]  
  • Suliman, H. B., Carraway, M. S., Welty-Wolf, K. E., Whorton, A. R., Piantadosi, C. A. (2003). Lipopolysaccharide Stimulates Mitochondrial Biogenesis via Activation of Nuclear Respiratory Factor-1. J. Biol. Chem. 278: 41510-41518 [Abstract] [Full Text]  
  • de Longueville, F., Atienzar, F. A., Marcq, L., Dufrane, S., Evrard, S., Wouters, L., Leroux, F., Bertholet, V., Gerin, B., Whomsley, R., Arnould, T., Remacle, J., Canning, M. (2003). Use of a Low-Density Microarray for Studying Gene Expression Patterns Induced by Hepatotoxicants on Primary Cultures of Rat Hepatocytes. Toxicol Sci 75: 378-392 [Abstract] [Full Text]  
  • James, D. I., Parone, P. A., Mattenberger, Y., Martinou, J.-C. (2003). hFis1, a Novel Component of the Mammalian Mitochondrial Fission Machinery. J. Biol. Chem. 278: 36373-36379 [Abstract] [Full Text]  
  • Hong, K. W., Kim, K. Y., Shin, H. K., Lee, J. H., Choi, J. M., Kwak, Y.-G., Kim, C. D., Lee, W. S., Rhim, B. Y. (2003). Cilostazol Prevents Tumor Necrosis Factor-{alpha}-Induced Cell Death by Suppression of Phosphatase and Tensin Homolog Deleted from Chromosome 10 Phosphorylation and Activation of Akt/Cyclic AMP Response Element-Binding Protein Phosphorylation. J. Pharmacol. Exp. Ther. 306: 1182-1190 [Abstract] [Full Text]  
  • Limoli, C. L., Giedzinski, E., Morgan, W. F., Swarts, S. G., Jones, G. D. D., Hyun, W. (2003). Persistent Oxidative Stress in Chromosomally Unstable Cells. Cancer Res. 63: 3107-3111 [Abstract] [Full Text]  
  • Zheng, Y., Vig, M., Lyons, J., Van Parijs, L., Beg, A. A. (2003). Combined Deficiency of p50 and cRel in CD4+ T Cells Reveals an Essential Requirement for Nuclear Factor {kappa}B in Regulating Mature T Cell Survival and In Vivo Function. JEM 197: 861-874 [Abstract] [Full Text]  
  • Li, N., Ragheb, K., Lawler, G., Sturgis, J., Rajwa, B., Melendez, J. A., Robinson, J. P. (2003). Mitochondrial Complex I Inhibitor Rotenone Induces Apoptosis through Enhancing Mitochondrial Reactive Oxygen Species Production. J. Biol. Chem. 278: 8516-8525 [Abstract] [Full Text]  
  • Manfredi, G., Kwong, J. Q., Oca-Cossio, J. A., Woischnik, M., Gajewski, C. D., Martushova, K., D'Aurelio, M., Friedlich, A. L., Moraes, C. T. (2003). BCL-2 Improves Oxidative Phosphorylation and Modulates Adenine Nucleotide Translocation in Mitochondria of Cells Harboring Mutant mtDNA. J. Biol. Chem. 278: 5639-5645 [Abstract] [Full Text]  
  • Ricci, J.-E., Gottlieb, R. A., Green, D. R. (2003). Caspase-mediated loss of mitochondrial function and generation of reactive oxygen species during apoptosis. JCB 160: 65-75 [Abstract] [Full Text]  
  • Gottlieb, E., Armour, S. M., Thompson, C. B. (2002). Mitochondrial respiratory control is lost during growth factor deprivation. Proc. Natl. Acad. Sci. USA 99: 12801-12806 [Abstract] [Full Text]  
  • Werner, E., Werb, Z. (2002). Integrins engage mitochondrial function for signal transduction by a mechanism dependent on Rho GTPases. JCB 158: 357-368 [Abstract] [Full Text]  
  • Gergely, P. Jr., Niland, B., Gonchoroff, N., Pullmann, R. Jr., Phillips, P. E., Perl, A. (2002). Persistent Mitochondrial Hyperpolarization, Increased Reactive Oxygen Intermediate Production, and Cytoplasmic Alkalinization Characterize Altered IL-10 Signaling in Patients with Systemic Lupus Erythematosus. J. Immunol. 169: 1092-1101 [Abstract] [Full Text]  
  • Mankoff, D. A., Dunnwald, L. K., Gralow, J. R., Ellis, G. K., Charlop, A., Lawton, T. J., Schubert, E. K., Tseng, J., Livingston, R. B. (2002). Blood Flow and Metabolism in Locally Advanced Breast Cancer: Relationship to Response to Therapy. JNM 43: 500-509 [Abstract] [Full Text]  
  • Kunisada, K., Tone, E., Negoro, S., Nakaoka, Y., Oshima, Y., Osugi, T., Funamoto, M., Izumi, M., Fujio, Y., Hirota, H., Yamauchi-Takihara, K. (2002). Bcl-xl reduces doxorubicin-induced myocardial damage but fails to control cardiac gene downregulation. Cardiovasc Res 53: 936-943 [Abstract] [Full Text]  
  • Madesh, M., Hajnoczky, G. (2001). VDAC-dependent permeabilization of the outer mitochondrial membrane by superoxide induces rapid and massive cytochrome c release. JCB 155: 1003-1016 [Abstract] [Full Text]  
  • Chandel, N. S., Schumacker, P. T., Arch, R. H. (2001). Reactive Oxygen Species Are Downstream Products of TRAF-mediated Signal Transduction. J. Biol. Chem. 276: 42728-42736 [Abstract] [Full Text]  
  • Musch, M. W., Kaplan, B., Chang, E. B. (2001). Role of Increased Basal Expression of Heat Shock Protein 72 in Colonic Epithelial c2BBE Adenocarcinoma Cells. Cell Growth Differ. 12: 419-426 [Abstract] [Full Text]  
  • Lesage, G., Glaser, S., Ueno, Y., Alvaro, D., Baiocchi, L., Kanno, N., Phinizy, J. L., Francis, H., Alpini, G. (2001). Regression of cholangiocyte proliferation after cessation of ANIT feeding is coupled with increased apoptosis. Am. J. Physiol. Gastrointest. Liver Physiol. 281: G182-G190 [Abstract] [Full Text]  
  • Chen, M.-C., Hsu, T.-L., Luh, T.-Y., Hsieh, S.-L. (2000). Overexpression of Bcl-2 Enhances LIGHT- and Interferon-gamma -mediated Apoptosis in Hep3BT2 Cells. J. Biol. Chem. 275: 38794-38801 [Abstract] [Full Text]  
  • Rogers, R. J., Monnier, J. M., Nick, H. S. (2001). Tumor Necrosis Factor-alpha Selectively Induces MnSOD Expression via Mitochondria-to-Nucleus Signaling, whereas Interleukin-1beta Utilizes an Alternative Pathway. J. Biol. Chem. 276: 20419-20427 [Abstract] [Full Text]  
  • Listenberger, L. L., Ory, D. S., Schaffer, J. E. (2001). Palmitate-induced Apoptosis Can Occur through a Ceramide-independent Pathway. J. Biol. Chem. 276: 14890-14895 [Abstract] [Full Text]  
  • Vander Heiden, M. G., Li, X. X., Gottleib, E., Hill, R. B., Thompson, C. B., Colombini, M. (2001). Bcl-xL Promotes the Open Configuration of the Voltage-dependent Anion Channel and Metabolite Passage through the Outer Mitochondrial Membrane. J. Biol. Chem. 276: 19414-19419 [Abstract] [Full Text]  

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gottlieb, E.
Right arrow Articles by Thompson, C. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gottlieb, E.
Right arrow Articles by Thompson, C. B.

Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»